account_balance
Investment manager · 13F filer · SEC CIK 1964437
Saturn V Capital Management LP
Reported value$697Mas of Jun 30, 2026
Positions23 3 new, 1 sold out
Top 10 weight75.6%AMLX alone is 12%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
AMLXAmylyx Pharmaceuticals Inc
11.9%Added +6%
ALMSAlumis Inc
11.8%Trimmed −9%
ABVXAbivax SA
9.9%Trimmed −4%
PCVXVaxcyte Inc
7.1%Added +3%
IMMXImmix Biopharma Inc
6.9%Added +26%
PHVSPharvaris N V
6.5%Added +9%
JAZZJazz Pharmaceuticals PLC
5.6%
CELCCelcuity Inc
5.6%Added +31%
IRONDisc Medicine Inc
5.5%Added +17%
CADLCandel Therapeutics Inc
4.9%Added +14%
XFORX4 Pharmaceuticals Inc
4.7%Added +8%
MNPRMonopar Therapeutics Inc
4.1%Trimmed −10%
AMLXAmylyx Pharmaceuticals Inc
11.9%Added +6%
ALMSAlumis Inc
11.8%Trimmed −9%
ABVXAbivax SA
9.9%Trimmed −4%
PCVXVaxcyte Inc
7.1%Added +3%
IMMXImmix Biopharma Inc
6.9%Added +26%
PHVS6.5%JAZZ5.6%CELC5.6%IRON5.5%CADL4.9%XFOR4.7%MNPR4.1%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
AMLX Amylyx Pharmaceuticals Inc 11.9% Added +6%ALMS Alumis Inc 11.8% Trimmed −9%ABVX Abivax SA 9.9% Trimmed −4%PCVX Vaxcyte Inc 7.1% Added +3%IMMX Immix Biopharma Inc 6.9% Added +26%PHVS Pharvaris N V 6.5% Added +9%JAZZ Jazz Pharmaceuticals PLC 5.6% HeldCELC Celcuity Inc 5.6% Added +31%IRON Disc Medicine Inc 5.5% Added +17%CADL Candel Therapeutics Inc 4.9% Added +14%XFOR X4 Pharmaceuticals Inc 4.7% Added +8%MNPR Monopar Therapeutics Inc 4.1% Trimmed −10%
What changed